In 2022, U.S. healthcare spending in elevated 4.1 % to $4.5 trillion, or $13,493 per individual (with per capita progress of three.7 %), in line with an evaluation from the Workplace of the Actuary on the Facilities for Medicare and Medicaid Providers (CMS).

The findings, printed on-line by Well being Affairs, point out that in 2022 robust progress in Medicaid and personal medical health insurance spending was offset by continued declines in supplemental funding by the federal authorities related to the COVID-19 pandemic. General, healthcare spending progress in 2022 was sooner than the three.2 % progress in 2021, however a lot slower than the speed of 10.6 % in 2020.  
 
The report notes that the healthcare spending improve of 4.1 % in 2022 was a lot slower than progress within the nominal gross home product (GDP), which elevated 9.1 %. In 2022, the share of the financial system dedicated to healthcare spending, as measured by the GDP, declined to 17.3 %, decrease than each the 18.2 % share in 2021 and the very best share in historical past of 19.5 % in 2020. On a per capita foundation, nationwide well being spending grew 3.7 %.

Progress in complete healthcare spending in 2022 mirrored a slowdown in private well being care spending (items and companies) that was greater than offset by sooner progress in non-personal healthcare spending. The slowdown in private well being care spending was attributable to slower progress in spending for hospital care (from 4.5 % in 2021 to 2.2 % in 2022), dental companies (from 18.2 % in 2021 to 0.3 % in 2022), and doctor and medical companies (from 5.3 % in 2021 to 2.7 % in 2022). Non-personal well being care spending accelerated in 2022 due largely to a turnaround within the internet value of insurance coverage.

Medicaid and personal medical health insurance spending additionally influenced progress in healthcare spending in 2022. Medicaid spending elevated 9.6 % in 2022 after progress of 9.4 % in 2021 and 9.3 % in 2020. Over the interval of 2019-22, cumulative Medicaid spending elevated 31 %, or 9.4 % per yr on common, and enrollment accounted for many of the progress because it elevated 24.6 %. Personal medical health insurance spending elevated 5.9 % in 2022 after a rise of 6.3 % in 2021 and a decline of 0.8 % in 2020.
 
“Healthcare expenditures since 2020 have mirrored unstable patterns related to the COVID-19 pandemic and the federal authorities’s response to the general public well being emergency,” mentioned Micah Hartman, a statistician within the CMS Workplace of the Actuary and first creator of the Well being Affairs article, in a press release. “The expansion in healthcare spending in 2022 of 4.1 % was extra per the pre-pandemic common annual progress price of 4.4 % over 2016-19. It stays to be seen how future healthcare spending developments will materialize, as developments are anticipated to be pushed extra by health-specific elements resembling medical-specific value inflation, the utilization and depth of medical care, and the demographic impacts related to the persevering with enrollment of the newborn boomers in Medicare.”
 
The variety of uninsured people declined for the third consecutive yr, from 28.5 million in 2021 to 26.6 million in 2022, because the insured share of the inhabitants elevated to 92.0 %—a historic excessive. Market enrollment elevated by 1.7 million folks in 2022, and employer-sponsored insurance coverage enrollment elevated by 1.5 million folks, accounting for 86 % of complete personal medical health insurance enrollment and 88 % of spending. Medicaid enrollment elevated by 6.1 million folks in 2022. (Nonetheless, at the very least 11,967,000 Medicaid enrollees have been disenrolled as of Dec. 7, 2023, primarily based on probably the most present information from all 50 states and the District of Columbia, in line with KFF.)

Retail prescription drug spending reached $405.9 billion in 2022 and represented 9 % of general well being spending. Progress in retail prescription drug spending was 8.4 % in 2022, sooner than the 6.8 % progress in 2021. The rise in spending progress for retail pharmaceuticals was attributable to a number of elements, together with sooner progress in utilization and costs in addition to shifts within the combine of medicine bought.